May 2025: MFI to present data on 15-min rest-stress PET with 18F-flurpiridaz at SNMMI conference in June
SEPT2022: MFI awarded Phase II SBIR grant to develop dual-tracer cancer imaging techniques
NOV2020: MFI awarded Phase I SBIR grant from National Cancer Institute
APR2019: MFI has been awarded a Phase I SBIR grant from the National Heart Lung and Blood Institute
OCT2019: MFI honored at 2019 Utah Innovation Awards in Life Science – Medical Device competition for mfiVerse™ software
JUN2018: MFI receives FDA 510(k) clearance for mfiVerse™ software
2013-2016: MFI receives $180k in grants from State of Utah Technology Commercialization and Innovation Program
MAY2012: International Innovations Editorial Features MFI and Kadrmas Lab